Koyfin Home > Directory > Health Care > Kindred Biosciences > Total Debt / EBITDA

Kindred Biosciences Total Debt / EBITDA Chart (KIN)

Kindred Biosciences annual/quarterly Total Debt / EBITDA from 2019 to 2020.
  • Kindred Biosciences Total Debt / EBITDA for the quarter ending June 06, 2020 was $-1m a 34.87% decrease of 0m year over year
  • Kindred Biosciences Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a 10.01% decrease of 0m year over year
Other Ratios Metrics:
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
View Chart On Koyfin

Quarterly KIN Total Debt / EBITDA Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m

Annual KIN Total Debt / EBITDA Data

2019$0m